Concepedia
Statistics
Publications
22
Citations
868
H-Index
15
Active since
2013
Affiliations
University of Würzburg(Current)
Universitätsklinikum Würzburg
Comprehensive Cancer Center Mainfranken
Saarland University
University Hospital of Bern
Charis Kalogirou is an author at University of Würzburg specializing in medicine, tumor microenvironment, and tumor biology.
Top concepts
MedicineUrologyTumor BiologyTumor MicroenvironmentPathologyPrognostic BiomarkersOncologyCell DeathPharmacologyClinical Chemistry
Publications per year
2013–2023
Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
Burkhard Kneitz, Markus Krebs, Charis Kalogirou et al. · Cancer Research · 2014 · 129 citations
Informative Biomarkers, Inhibiting Irf2, Cell Death +18
Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress
Irem Kaymak, Carina R. Maier, Werner Schmitz et al. · Cancer Research · 2019 · 88 citations · Full text
Long‐term results of ileal ureteric replacement: a 25‐year single‐centre experience
Arkadius Kocot, Charis Kalogirou, Daniel Vergho et al. · British Journal of Urology · 2017 · 80 citations
MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer
Charis Kalogirou, Johannes Linxweiler, Philipp Schmucker et al. · Nature Communications · 2021 · 72 citations · Full text
miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro
Markus Krebs, Antonio Giovanni Solimando, Charis Kalogirou et al. · Journal of Clinical Medicine · 2020 · 64 citations · Full text
1–5 of 22